Summit Therapeutics PLC (SMMT)

Summit Therapeutics PLC (SMMT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $12.3B; returns 1 day -0.5%, 1 week +5.7%, 1 year -17.5%.

Summit Therapeutics Inc. (NASDAQ: SMMT) is a biopharmaceutical company focused on discovering, developing, and commercializing medicinal therapies for unmet medical needs, particularly in oncology. Their lead candidate is Ivonescimab, a bispecific antibody combining immunotherapy and anti-angiogenesis effects. Ivonescimab is designed to block PD-1 and VEGF in a single molecule.

Groups SMMT belongs to

• Biotechnology
• Oncology
• Bispecific Antibodies
• Biopharmaceutical
• Clinical Stage Biotech
• Cancer Therapeutics
• PD-L1
• Immunotherapy
• Healthcare
• Clinical Stage
• Unmet Medical Needs

SMMT financial model: income statement, cash flow and balance sheet